Search Results 11-20 of 27046 for Adenocarcinoma%2C%20Non-Small%20Cell%2C%20Lung%20Cancer%2C%20Stage%20IV

  1. Ruxolitinib in Combination with Pemetrexed/Cisplatin in Non Small Cell Lung Cancer - Mayo Clinic

    Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. ... 2. During the early phases (phases 1 and 2) ... small cell lung cancer ...

  2. Aim 2: Develop Novel Approaches for Primary and Secondary Prevention - Population Sciences Program - Mayo Clinic Comprehensive Cancer Center Research

    Chemoprevention, tobacco cessation, human papillomavirus and obesity; Behavioral and communication interventions; Cancer screening and early detection. Major ...

  3. Radiation Therapy in Treating Patients with Extensive Stage Small Cell Lung Cancer - Mayo Clinic

    RATIONALE: Radiation therapy uses high energy x-rays to kill tumor cells. This may be an effective treatment for extensive stage small cell lung cancer. PURPOSE ...

  4. A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors - Mayo Clinic

    The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of CYT-0851 in patients with relapsed/refractory B-cell malignancies ...

  5. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    About this study. This phase II trial studies how well pembrolizumab works in treating patients with small bowel adenocarcinoma that has spread to other ...

  6. Project 2: Therapeutic Inhibition of Fibroblast Growth Factor and YAP Signaling in Cholangiocarcinoma - Mayo Clinic Comprehensive Cancer Center Research

    Mayo Clinic Hepatobiliary SPORE researchers are examining the cellular mechanisms for development of intrahepatic cholangiocarcinoma (cancer of the bile ...

  7. Mayo Clinic Comprehensive Cancer Center — Research

    Patients will be enrolled into 1 of 2 cohorts. Cohort 1 will consist of patients who are treatment-naïve and ineligible for platinum-containing therapy. Cohort ...

  8. CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/​B Non-Small Cell Lung Cancer - Mayo Clinic

    CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/​B Non-Small Cell Lung Cancer ... Study phase2. Study type.

  9. A Phase 1b/2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma - Mayo Clinic

    Clinical Trials · A Phase 1b/2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma · More about research at Mayo Clinic · Mayo ...

  10. Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients with Early Stage Non-Small Lung Cancer (NSCLC) - Mayo Clinic

    Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients with Early Stage Non-Small Lung Cancer (NSCLC) ... 2 years between ...